Fagopyritol synthase genes and uses thereof

Details Fagopyritol synthase genes and uses thereof Fagopyritol synthase genes and uses thereof

2003-05-09

2010-10-05

Hutson, Richard G (Department: 1652)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C514S035000, C514S025000, C514S053000, C536S123100

Reexamination Certificate

active

07807406

ABSTRACT:
The present invention relates to an isolated DNA molecule encoding a fagopyritol synthase. A method for producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor is also described. The method includes providing a fagopyritol synthase, providing a substrate comprising a galactosyl donor and a galactosyl acceptor, and combining the fagopyritol synthase with the substrate under conditions effective produce a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor.

REFERENCES:
patent: 2112553 (1938-03-01), Bartow et al.
patent: 2456470 (1948-12-01), Thomas
patent: 3270064 (1966-08-01), Inaba et al.
patent: 4010258 (1977-03-01), Murao
patent: 4482761 (1984-11-01), Chao et al.
patent: 4933281 (1990-06-01), Daniels et al.
patent: 5064762 (1991-11-01), Rabinowitz
patent: 5091596 (1992-02-01), Kennington et al.
patent: 5096594 (1992-03-01), Rabinowitz
patent: 5122603 (1992-06-01), Larner et al.
patent: 5124360 (1992-06-01), Larner et al.
patent: 5296364 (1994-03-01), Agawal
patent: 5317095 (1994-05-01), Suzuki et al.
patent: 5406005 (1995-04-01), Piccariello
patent: 5463142 (1995-10-01), Riley et al.
patent: 5516950 (1996-05-01), Piccariello et al.
patent: 5648210 (1997-07-01), Kerr et al.
patent: 5710365 (1998-01-01), Kerr et al.
patent: 5827896 (1998-10-01), Ostlund et al.
patent: 6093697 (2000-07-01), Larner et al.
patent: 6162795 (2000-12-01), Obendorf et al.
patent: 6486127 (2002-11-01), Gunn et al.
patent: 6492341 (2002-12-01), Obendorf et al.
patent: 6753461 (2004-06-01), Taji et al.
patent: 3-11026(A) (1991-01-01), None
patent: WO 93/02196 (1993-02-01), None
patent: WO 98/50049 (1998-11-01), None
patent: WO 01/89352 (2001-11-01), None
Nestler et al., “Ovulatory and Metabolic Effects of D-Chiro-inositol in the Polycystic Ovary Syndrome,”New England Journal of Medicine, 340(17):1314-1320 (1999).
Ogawa et al., “A New Glycoside, 1D-2-O-α-D-Galactopyranosyl-Chiro-Inositol from Jojoba Beans,”Carbohydrate Res., 302:219-221 (1997).
Kornienko et al., “Synthesis of a Jojoba Bean Disaccharide,”Carbohydrate Res., 310:141-144 (1998).
Berlin et al., “Glycosyl-Inositol Derivatives II. Synthesis of 2-Amino-2-Deoxy-D-Galactosyl-α-1,3-D-Chiro-Inositol,”Tetrahedron Lett., 31(8):1109-1112 (1990).
Richter et al., “Structure of Galactosylononitol,”J. Nat. Prod., 60(8):749-751 (1997).
Petek et al., “Isolation of Two Galactosidases of Myo-inositol from Vetch seeds,”C.R. Acad. Sc. Paris Sciences Série D, 263:195-197 (1966).
Petek et al., “Purification and Properties of the α-Galactosidase of the Germinating Seed ofVicia sativa,”European J. Biochemistry, 8:395-402 (1969) (Abstract).
Gao et al., “A Novel Alkaline α-Galactosidase from Melon Fruit with a Substrate Preference for Raffinose,”Plant Physiology, 119:979-987 (1999).
Larner et al., “Rat Liver Insulin Mediator Which Stimulates Pyruvate Dehydrogenase Phosphatase Contains Galactosamine and D-Chiroinositol,”Biochemical and Biophysical Research Communications, 151(3):1416-1426 (1988).
Schweizer et al., “Low Molecular Weight Carbohydrates From Leguminous Seeds; A New Disaccharide: Galactopinitol,”J. Sci. Fd Agric., 29:148-154 (1978).
Schweizer et al., “Purification and Structure Determination of Three α-D-galactopyranosylcyclitols From Soya Bean,”Carbo. Res., 95:61-71 (1981).
Shiomi et al., “A New Digalactosyl Cyclitol From Seed Balls of Sugar Beet,”Agric. Biol. Chem., 52:1587-1588 (1988).
Ortmeyer et al., “In vivo D-chiroinositol Activates Skeletal Muscle Glycogen Synthase and Inactivates Glycogen Phosphorylase in Rhesus Monkeys,”Nutritional Biochemistry, 6:499-503 (1995).
Ortmeyer et al., “Effects of D-Chiroinositol Added to a Meal on Plasma Glucose and Insulin In Hyperinsulinemic Rhesus Monkeys,”Obesity Res., 3 (Supp 4):605S-608S (1995).
Horbowicz et al., “Maturing Buckwheat Seeds Accumulate Galacto-chiro-inositol Instead of Stachyose,” Abstract 908,Plant Physiology, 105:S-164 (1994).
Horbowicz et al., “Galactosyl-chiro-inositol in Buckwheat Seeds Correlates with Desiccation Tolerance During Maturation and Germination,”Agronomy Abst., 178 (1994).
Horbowicz et al., “Fagopyritol B1, O-α-D-galactopyranosyl-(1→2)-D-chiro-inositol, a Galactosyl Cyclitol in Maturing Buckwheat Seeds Associated with Desiccation Tolerance,”Planta, 205:1-11 (1998).
Szczecinski et al., “NMR Investigation of the Structure of Fagopyritol B1 from Buckwheat Seeds,”Bulletin of the Polish Academy of Sciences Chemistry, 46(1):9-13 (1998).
Yasui, “Dissimilarity in Low Molecular Weight Carbohydrate Composition of the Seeds of Cultivated Soybean [Glycine max (L.) Merrill subsp. max] and Wild Soybean [G. max subsp. soja (Sieb. et Zucc.) Ohashi],”Agric. Biol. Chem., 49:933-937 (1985).
Quemener et al., “Ciceritol, a Pinitol Digalactoside from Seeds of Chickpea, Lentil and White Lupin,”Phytochemistry, 22:1745-1751 (1983).
Obendorf et al., “Seed Desiccation Tolerance and Storability: Dependence on the Flatulence-Producing Sugars,” International Workshop: Desiccation Tolerance and Sensitivity of Seeds and Vegetative Plant Tissues, South Africa, Jan. 19, 1994 (Abstract of Oral Presentation).
Obendorf et al., “Seed Set and Cessation of Seed Growth in Buckwheat,” Developing a Strategic Plan for Integrated Buckwheat Research, North Dakota State University Research and Extension Center, Jul. 21, 1994, (Abstract of Oral Presentation).
Obendorf et al., “Seed Set and Cessation of Seed Growth in Buckwheat,” Quarterly Report to Sponsors, Apr. 1-Jun. 30, 1994.
Obendorf, “Buckwheat Pharmaceuticals: 1. Characterization,” “Buckwheat Pharmaceuticals: 2. Model for Industrial Isolation,” “Buckwheat Pharmaceuticals: 3. Equipment,” Research Proposals to MINN-DAK Growers Ltd. (Nov. 27, 1995).
Obendorf et al., “Buckwheat Pharmaceuticals: Buckwheat Project 1999 Annual Report,” (1999).
Steadman et al., “Minerals, Phytic Acid, Tannin and Rutinin Buckwheat Seed Milling Fractions,”J. Sci. Food Agric., 81:1094-1100 (2001).
Steadman et al., “Fagopyritols, D-chiro-Inositol, and Other Soluble Carbohydrates in Buckwheat Seed Milling Fractions,”J. Agric. Food Chem., 48:2843-2847 (2000).
Steadman et al., “Buckwheat Seed Milling Fractions: Description, Macronutrient Composition and Dietary Fibre,”J. Cereal Sci., 33:271-278 (2001).
Brenac et al., “Fagopyritol and Raffinose Oligosaccharides Related to Dessication Tolerance of Buckwheat Hypocotyes,”Plant Physiology, 108:S-19 (1995).
Chien et al., “Occurrence of a Novel Galactopinitol and its Changes with Other Non-Reducing Sugars During Development ofLeucaena leucocephalaSeeds,”Plant and Cell Physiology37:539-544 (1996) (Abstract).
Obendorf et al., “Soluble Oligosaccharides and Galactosyl Cyclitols in Maturing Soybean Seeds in planta and in vitro,”Crop Sci.38:78-84 (1998) (Abstract).
Horbowicz et al., “Seed Dessication Tolerance and Storability: Dependence on Flatulence-Producing Oligosaccharides and Cyclitols—Review and Survey,”Seed Sci. Res.4:385-405 (1994) (Abstract).
Larner et al., “Identification of a Novel Inositol Glycan Signaling Pathway with Significant Therapeutic Relevance to Insulin Resistance: An Insulin Signaling Model Using both Tyrosine Kinase and G-Proteins,”Diabetes Reviews, 7:217-231 (1999).
ICMR Central Technical Co-ordinating Unit, “Multicentric Study of Efficacy of Periconceptional Folic Acid Containing Vitamin Supplementation in Prevention of Open Neural Tube Defects from India,”Indian J. Med. Res.112:206-211 (2000) (Abstract).
Harmon et al., “Prena

Affiliated with

Also associated with

Rating

Fagopyritol synthase genes and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fagopyritol synthase genes and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fagopyritol synthase genes and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4199611